Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0019 | 1 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |